finance
Latest news and updates from Finance.
Corporate
February 3, 2025
Sun Pharma registers adjusted net profit of Rs 3219.6 Cr in Q3FY25
Q3 Gross Sales at Rs 134,369 million up 10.5 per cent YoY Sun Pharmaceutical Industries reported financials for the third quarter ending December 31, 2024. Highlights of Q3FY25 consolidated financials* · Gross sales at Rs 134,369 million, growth of 10.5 per cent · India formulation sales at Rs 43,004 million, up 13.8 per cent · US formulation sales at $474 million, down 0.7 […]
Finance
February 3, 2025
Aster DM Healthcare registers Rs 3138 Cr revenue in 9M FY25
In 9M FY25, the operating EBITDA was up 35 per cent YoY to Rs 613 crores Aster DM Healthcare announced its financial results for the quarter ended December 31, 2024. Key Financial Highlights Revenue · Revenue grew 15 per cent YoY to Rs 3,138 crores in 9M FY25 Vs. Rs 2,721 crores in 9M FY24. · Revenue […]
Finance
January 31, 2025
Ayushman Yojana results in significant reduction of out-of-pocket expenditure: Economic Survey
Over Rs 1.25 lakh crore savings recorded The Economic Survey 2024-25 tabled in Parliament today talked about government initiatives, including preventive measures, universal access to high-quality healthcare, strengthened public health infrastructure, and advancements in medical education, which have collectively contributed to making healthcare in India more accessible and affordable for all. As per the Economic […]
Corporate
January 31, 2025
Hester Biosciences posts net profit of Rs 11.41 Cr in Q3FY25
In 9M FY25 the net profit has been up 85 per cent Y-o-Y to Rs 27.29 crore Ahmedabad-based Hester Biosciences has reported a consolidated net profit of Rs 11.41 crore in Q3FY25 ended December 2024 as against a net profit of Rs 4.02 crore in Q3FY24, a growth of 184 per cent. The company reported […]
Corporate
January 29, 2025
OneSource Specialty Pharma posts Rs 3,926 M revenues in Q3FY25
EBITDA grew 85 per cent QoQ to Rs 1,432 million OneSource Specialty Pharma announced the consolidated financial results for the quarter (Q3FY25) ended December 31, 2024. Q3FY25 Performance Highlights · Revenues of Rs 3,926 million grew 18 per cent QoQ. · EBITDA grew 85 per cent QoQ to Rs 1,432 million. · EBITDA margin of 36.5 per cent […]
Finance
January 28, 2025
InvAscent invests Rs 1,100 M in Geri Care Health Services
Geri Care intends to utilise the funds to expand its services across key cities in Southern India, including Bengaluru, Hyderabad, Kochi and Coimbatore Healthcare and life sciences-focused private equity investor, InvAscent, through India Life Sciences Fund IV (ILSF IV), has invested Rs 1,100 million in Geri Care Health Services, India’s first integrated senior citizen-focused healthcare […]
Finance
January 27, 2025
India’s health aspirations fall short: The elusive 2.5 per cent GDP spending target
By Varshith SV India’s healthcare industry, currently valued at approximately $372 billion, is projected to grow to nearly double to over $638 billion by 2030, driven by advancements in medical technology, increased public awareness, and government initiatives like Ayushman Bharat. Yet, the country faces a daunting challenge: bridging the gap between its potential and the […]
Corporate
January 24, 2025
Granules registers decline in revenue from operations for Q3FY25
Granules India, announced its financial results for the quarter ended December 31, 2024. Revenue from operations of Q3FY25 stood at Rs 11,377 million, a decline of 2 per cent YoY. Revenue share from North America increased to 77 per cent in Q3 FY25, compared to 66 per cent in Q3 FY24. Finished dosages (FD), Active […]
Corporate
January 24, 2025
Mankind Pharma posts Rs 3230 Cr revenue in Q3 FY25
The 9M FY25 registers Rs 9200 crore revenue Mankind Pharma announced its financial results for the third quarter and nine months ended December 31, 2024. The information mentioned in this release is based on consolidated financial statements. Rajeev Juneja – Vice Chairman and Managing Director, Mankind Pharma said, “We achieved a healthy revenue growth of […]
Corporate
January 23, 2025
Senores Pharma registers Rs 288 Cr revenue in 9MFY25
The company posted an EBITDA of Rs 74 crore which is 287 per cent increase Ahmedabad-based Senores Pharmaceuticals has reported revenue of Rs 288 crore during 9MFY25 ending December 31, 2024, reflecting a robust growth of 157 per cent. The exceptional financial performance underscores the company’s strong business strategies and operational excellence. Key highlights Swapnil […]
Subscribe to IMT
Join 15,000+ healthcare professionals getting our daily intelligence.
No spam. Unsubscribe anytime.
Recommended
Featured Article
July 10, 2026
India’s first focused health AI Conclave unites doctors and AI experts
News
July 10, 2026
Fischer Medical Ventures Highlights NYB.AI Partnership as Platform Showcased at NVIDIA GTC Taiwan 2026
News
July 10, 2026
Pharma Q1 Margins Seen Under Pressure Despite Revenue Growth: Goldman Sachs
News
July 10, 2026
Dr Reddy’s Delays Semaglutide Supplies After Active Ingredient Quality Issue
News
July 10, 2026